Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA Approves Natalizumab For Sandoz And Polpharma Biologics
Tyruko Biosimilar Rival To Tysabri Approved In US Following Recent European Nod
Aug 25 2023
•
By
David Wallace
Tyruko has now been approved in the US • Source: Shutterstock
More from Products
More from Generics Bulletin